Clinical trial
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating…
NCT00128700 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00128700 |
|---|---|
| Title | Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | Phase I/II Study on Concomitant and Adjuvant Temozolomide and Radiotherapy With or Without PTK787/ZK222584 in Newly Diagnosed GBM |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | temozolomide, vatalanib, adjuvant therapy, radiation therapy |
| Enrollment | 20 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2007 |
| First posted | Aug 10, 2005 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, Germany, Italy, Netherlands, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: